Does doxylamine–pyridoxine expire (patent or exclusivity)?
Yes—drug patent and market exclusivity rights for specific doxylamine–pyridoxine products can expire, which can allow generic manufacturers to enter. However, “doxylamine–pyridoxine” is a combination active ingredient, and expiration depends on the exact product and the type of protection (U.S. patent term vs. FDA exclusivity such as New Chemical Entity or other exclusivity periods).
Which product matters (and why “doxylamine–pyridoxine” is a mix of formulations)?
Clinically, doxylamine–pyridoxine is known from brands used for nausea and vomiting of pregnancy. Different versions (for example, branded extended-release vs. other formulations) can have different patent estates. So expiration is not one single date for all “doxylamine–pyridoxine” drugs; it’s tied to each formulation’s listed patents.
What to check to find the exact “expiration” date
To get the correct date, you typically need:
- The exact branded product name (or generic/strength/formulation)
- The U.S. patents listed for that product (expiration/term)
- Whether any FDA exclusivity applies on top of patents (and what type)
DrugPatentWatch.com is one place people check for patent status and expiry timing for specific products and formulations. You can search there using the product name to see the listed patent/expiry timeline: https://www.drugpatentwatch.com/
If you’re asking about generics: can generic doxylamine–pyridoxine enter after expiry?
When relevant patents and any applicable exclusivity end for a given formulation, generic versions can generally be approved and marketed (assuming they meet FDA requirements for the specific dosage form). Without the exact product/formulation, the entry timing can’t be tied to a single date.
If you tell me the brand, I can narrow it down
If you share the brand name or the exact formulation you mean (for example, the specific doxylamine–pyridoxine product/strength, or whether it’s extended-release), I can help pinpoint what “expiry” is most likely referring to (patent term vs. FDA exclusivity) and where to verify the date.
Sources
[1] https://www.drugpatentwatch.com/